Skip to main content
. 2016 Nov 11;16:877. doi: 10.1186/s12885-016-2940-7

Fig. 5.

Fig. 5

Sensitivity analysis on the prognostic value of mTOR/p-mTOR expression for (a) OS, (b) DFS and (c) CSS in patients with ESCC. CI, confidence interval; CSS, cancer-specific survival; DFS, disease-free survival; ESCC, esophageal squamous cell carcinoma; mTOR, mammalian target of rapamycin; p-mTOR, phosphorylated mammalian target of rapamycin; OS, overall survival